Gender differences in survival following hospitalisation for COPD

Thorax

Volumn 66, Issue 1, 2011, Pages 38-42

  Gonzalez, Anne V ^a   Suissa, Samy ^b   Ernst, Pierre ^b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; IPRATROPIUM BROMIDE; THEOPHYLLINE;

AGED; ARTICLE; ASTHMA; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; FEMALE; FOLLOW UP; GERIATRIC PATIENT; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; SURVIVAL;

EID: 78650225104     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2010.141978     Document Type: Article

References (29)

1. Anon. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary, 2006. http://www.goldcopd.org/.
2. Murray CJL, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997;349:1498-504.
3. Mannino DM, Homa DM, Akinbami LJ, et al. Chronic obstructive pulmonary disease surveillance: United States, 1971-2000. MMWR Morb Mortal Wkly Rep 2002;51:SS6.
4. de Torres JP, Casanova C, Hernandez C, et al. Gender and COPD in patients attending a pulmonary clinic. Chest 2005;128:2012-16.
5. Chapman KR. Chronic obstructive pulmonary disease: are women more susceptible than men? Clin Chest Med 2004;25:331-41.
6. Prescott E, Bjerg AM, Andersen PK, et al. Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study. Eur Respir J 1997;10:822-7.
7. Martinez FJ, Curtis JL, Sciurba F, et al. Sex differences in severe pulmonary emphysema. Am J Respir Crit Care Med 2007;176:243-52.
8. Machado MCL, Krishnan JA, Buist SA, et al. Sex differences in survival of oxygen-dependent patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006;174:524-9.
9. de Torres JP, Cote CG, Lopez MV, et al. Sex differences in mortality in patients with COPD. Eur Respir J 2009;33:528-35.
10. Gonzalez AV, Suissa S, Ernst P. Gender differences in survival following COPD hospitalization. Am J Respir Crit Care Med 2010;181:A1520.
11. Tamblyn R, Lavoie G, Petrella L, et al. The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims databases in Quebec. J Clin Epidemiol 1995;48:999-1009.
12. Miyamoto K, Aida A, Nishimura M, et al. Gender effect on prognosis of patients receiving long-term home oxygen therapy. Am J Respir Crit Care Med 1995;152:972-6.
13. Crockett AJ, Cranston JM, Moss JR, et al. Survival on long-term oxygen therapy in chronic airflow limitation: from evidence to outcomes in the routine clinical setting. Intern Med J 2001;31:448-54.
14. Franklin KA, Gustafson T, Ranstam J, et al. Survival and future need of long-term oxygen therapy for chronic obstructive pulmonary disease: gender differences. Respir Med 2007;101:1506-11.
15. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350:1005-12.
16. Vestbo J, Prescott E, Lange P, et al. Vital prognosis after hospitalization for COPD: a study of a random population sample. Respir Med 1998;92:772-6.
17. Dodge RR, Burrows B. The prevalence and incidence of asthma and asthma-like symptoms in a general population sample. Am Rev Respir Dis 1980;122:567575.
18. Chapman KR, Tashkin DP, Pye DJ. Gender bias in the diagnosis of COPD. Chest 2001;119:1691-5.
19. Burrows B, Earle RH. Course and prognosis of chronic obstructive lung disease. A prospective study of 200 patients. N Engl J Med 1969;280:397-404.
20. Almagro P, Calbo E, Ochoa de Echagüen A, et al. Mortality after hospitalization for COPD. Chest 2002;121:1441-8.
21. Mannino DM, Doherty DE, Sonia BA. Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study. Respir Med 2006;100:115-22.
22. Andreev K. Sex differentials in survival in the Canadian population, 1921-1997: a descriptive analysis with focus on age-specific structure. Demogr Res 2000;3:12.
23. Von Korff M, Wagner EH, Saunders K. A chronic disease score from automated pharmacy data. J Clin Epidemiol 1992;45:197-203.
24. Di Marco F, Verga M, Reggente M, et al. Anxiety and depression in COPD patients: the roles of gender and disease severity. Respir Med 2006;100:1767-74.
25. Gudmundsson G, Gislason T, Janson C, et al. Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression. Eur Respir J 2005;26:414-19.
26. Ernst PP, Bourbeau J, Rainville B, et al. Underestimation of COPD as a cause of death. Eur Respir J 2000;16(Suppl 31):13S.
27. Dransfield MT, Washko GR, Foreman MG, et al. Gender differences in the severity of CT emphysema in COPD. Chest 2007;132:464-70.
28. Camp PG, Coxson HO, Levy RD, et al. Sex differences in emphysema and airway disease in smokers. Chest 2009;136:1480-8.
29. Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax 2009;64:728-35.